Fulcrum Therapeutics Announces Additional HBG mRNA Induction from Higher Dose Cohorts in Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease and New Preclinical Mechanism Data.
In: Contify Life Science News, 2021-12-06
Zeitungsartikel
Zugriff:
Titel: |
Fulcrum Therapeutics Announces Additional HBG mRNA Induction from Higher Dose Cohorts in Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease and New Preclinical Mechanism Data.
|
---|---|
Zeitschrift: | Contify Life Science News, 2021-12-06 |
Veröffentlichung: | 2021 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|